<DOC>
	<DOCNO>NCT01597921</DOCNO>
	<brief_summary>The purpose study evaluate effect topical R1 R2 prophylaxis acute radiation dermatitis patient breast cancer receive radiotherapy .</brief_summary>
	<brief_title>A DB Randomized Study R1 R2 WaterJel / AloeVera Jell Prevention Radiation Dermatitis Breast Cancer</brief_title>
	<detailed_description>All woman give two type Jell . One apply immediately radiation second one , 3 time every day . All woman complete detailed questionnaire every two week evaluate treat team time.All woman evaluate two week end radiation period .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Erythema</mesh_term>
	<mesh_term>Radiodermatitis</mesh_term>
	<criteria>1 . Woman histologically confirm breast cancer underwent lumpectomy require adjuvant radiation therapy 2 Gy/fx total dose 50 Gy . 2 . Women receive neoadjuvant adjuvant chemotherapy eligible study . Three week minimal interval chemotherapy start radiation therapy . 3 . Patient able understand study design cooperate instruction use . 4 . Patient able sign inform consent 1 . Woman lactose allergy ( lactose intolerance eligible ) 2 . Woman known connective tissue disorder 3 . Woman uncontrolled diabetes 4 . Patients receive radiation protocol 2.64 Gy/fx 1.8 Gy/fx 5 . Woman unable sign inform consent</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Breast conserving surgery</keyword>
	<keyword>Radiation dermatitis</keyword>
</DOC>